Synopsis
Synopsis
0
EU WC
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
Australia
0
US Patents
0
US Exclusivities
0
Health Canada Patents
Annual Reports
NA
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Chloride, Magnesium
2. Magnesium Chloride
3. Mgcl2
1. Magnesium Dichloride Hexahydrate
2. Bischofite
3. Polycatan
4. Magnesia Muriatica
5. Magnesium Chloride, Hexahydrate
6. Ccris 3494
7. Magnesium;dichloride;hexahydrate
8. Bischofite (mgcl2.6h2o)
9. Chlorure De Magnesium Hydrate
10. Magnesium Chloride Hydrate (mgcl2.6h2o)
11. Ins No.511
12. Chebi:86345
13. Ins-511
14. 02f3473h9o
15. E-511
16. Chlorure De Magnesium Hydrate [french]
17. Mgcl2.6h2o
18. Magnesium Chloride [usp]
19. Magnesium Chloride [ii]
20. Chembl3185229
21. Dtxsid0020789
22. Magnesium Chloride [fcc]
23. Magnesium Chloride [jan]
24. Unii-02f3473h9o
25. Magnesia Muriatica [hpus]
26. Magnesium Chloride [inci]
27. Magnesium Chloride [vandf]
28. Magnesium(ii)-chloride Hexahydrate
29. Magnesium Chloride [usp-rs]
30. Magnesium Dichloride--water (1/6)
31. Akos015855540
32. Magnesium Chloride [orange Book]
33. Ncgc00248737-01
34. Magnesium Chloride [usp Monograph]
35. Magnesium(ii) Chloride Hexahydrate
36. Magnesium Chloride Hexahydrate [mi]
37. Ft-0628076
38. Magnesium Chloride Hexahydrate A.c.s.reagent
39. Normocarb Component Magnesium Chloride
40. Magnesium Chloride Hexahydrate [who-dd]
41. Magnesium Chloride Component Of Normocarb
42. Magnesium Chloride Hexahydrate 46.5% Min Mgcl2
43. Magnesium Chloride Hexahydrate [ep Monograph]
44. Q19364448
45. 13778-96-6
Molecular Weight | 203.30 g/mol |
---|---|
Molecular Formula | Cl2H12MgO6 |
Hydrogen Bond Donor Count | 6 |
Hydrogen Bond Acceptor Count | 8 |
Rotatable Bond Count | 0 |
Exact Mass | 201.9861352 g/mol |
Monoisotopic Mass | 201.9861352 g/mol |
Topological Polar Surface Area | 6 Ų |
Heavy Atom Count | 9 |
Formal Charge | 0 |
Complexity | 0 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 9 |
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
ABOUT THIS PAGE
45
PharmaCompass offers a list of Magnesium Chloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Magnesium Chloride manufacturer or Magnesium Chloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Magnesium Chloride manufacturer or Magnesium Chloride supplier.
PharmaCompass also assists you with knowing the Magnesium Chloride API Price utilized in the formulation of products. Magnesium Chloride API Price is not always fixed or binding as the Magnesium Chloride Price is obtained through a variety of data sources. The Magnesium Chloride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A AMINOSYN II 10% W/ ELECTROLYTES manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of AMINOSYN II 10% W/ ELECTROLYTES, including repackagers and relabelers. The FDA regulates AMINOSYN II 10% W/ ELECTROLYTES manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. AMINOSYN II 10% W/ ELECTROLYTES API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of AMINOSYN II 10% W/ ELECTROLYTES manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A AMINOSYN II 10% W/ ELECTROLYTES supplier is an individual or a company that provides AMINOSYN II 10% W/ ELECTROLYTES active pharmaceutical ingredient (API) or AMINOSYN II 10% W/ ELECTROLYTES finished formulations upon request. The AMINOSYN II 10% W/ ELECTROLYTES suppliers may include AMINOSYN II 10% W/ ELECTROLYTES API manufacturers, exporters, distributors and traders.
click here to find a list of AMINOSYN II 10% W/ ELECTROLYTES suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A AMINOSYN II 10% W/ ELECTROLYTES DMF (Drug Master File) is a document detailing the whole manufacturing process of AMINOSYN II 10% W/ ELECTROLYTES active pharmaceutical ingredient (API) in detail. Different forms of AMINOSYN II 10% W/ ELECTROLYTES DMFs exist exist since differing nations have different regulations, such as AMINOSYN II 10% W/ ELECTROLYTES USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A AMINOSYN II 10% W/ ELECTROLYTES DMF submitted to regulatory agencies in the US is known as a USDMF. AMINOSYN II 10% W/ ELECTROLYTES USDMF includes data on AMINOSYN II 10% W/ ELECTROLYTES's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The AMINOSYN II 10% W/ ELECTROLYTES USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of AMINOSYN II 10% W/ ELECTROLYTES suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The AMINOSYN II 10% W/ ELECTROLYTES Drug Master File in Japan (AMINOSYN II 10% W/ ELECTROLYTES JDMF) empowers AMINOSYN II 10% W/ ELECTROLYTES API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the AMINOSYN II 10% W/ ELECTROLYTES JDMF during the approval evaluation for pharmaceutical products. At the time of AMINOSYN II 10% W/ ELECTROLYTES JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of AMINOSYN II 10% W/ ELECTROLYTES suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a AMINOSYN II 10% W/ ELECTROLYTES Drug Master File in Korea (AMINOSYN II 10% W/ ELECTROLYTES KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of AMINOSYN II 10% W/ ELECTROLYTES. The MFDS reviews the AMINOSYN II 10% W/ ELECTROLYTES KDMF as part of the drug registration process and uses the information provided in the AMINOSYN II 10% W/ ELECTROLYTES KDMF to evaluate the safety and efficacy of the drug.
After submitting a AMINOSYN II 10% W/ ELECTROLYTES KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their AMINOSYN II 10% W/ ELECTROLYTES API can apply through the Korea Drug Master File (KDMF).
click here to find a list of AMINOSYN II 10% W/ ELECTROLYTES suppliers with KDMF on PharmaCompass.
A AMINOSYN II 10% W/ ELECTROLYTES CEP of the European Pharmacopoeia monograph is often referred to as a AMINOSYN II 10% W/ ELECTROLYTES Certificate of Suitability (COS). The purpose of a AMINOSYN II 10% W/ ELECTROLYTES CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of AMINOSYN II 10% W/ ELECTROLYTES EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of AMINOSYN II 10% W/ ELECTROLYTES to their clients by showing that a AMINOSYN II 10% W/ ELECTROLYTES CEP has been issued for it. The manufacturer submits a AMINOSYN II 10% W/ ELECTROLYTES CEP (COS) as part of the market authorization procedure, and it takes on the role of a AMINOSYN II 10% W/ ELECTROLYTES CEP holder for the record. Additionally, the data presented in the AMINOSYN II 10% W/ ELECTROLYTES CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the AMINOSYN II 10% W/ ELECTROLYTES DMF.
A AMINOSYN II 10% W/ ELECTROLYTES CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. AMINOSYN II 10% W/ ELECTROLYTES CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of AMINOSYN II 10% W/ ELECTROLYTES suppliers with CEP (COS) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing AMINOSYN II 10% W/ ELECTROLYTES as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for AMINOSYN II 10% W/ ELECTROLYTES API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture AMINOSYN II 10% W/ ELECTROLYTES as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain AMINOSYN II 10% W/ ELECTROLYTES and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a AMINOSYN II 10% W/ ELECTROLYTES NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of AMINOSYN II 10% W/ ELECTROLYTES suppliers with NDC on PharmaCompass.
AMINOSYN II 10% W/ ELECTROLYTES Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of AMINOSYN II 10% W/ ELECTROLYTES GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right AMINOSYN II 10% W/ ELECTROLYTES GMP manufacturer or AMINOSYN II 10% W/ ELECTROLYTES GMP API supplier for your needs.
A AMINOSYN II 10% W/ ELECTROLYTES CoA (Certificate of Analysis) is a formal document that attests to AMINOSYN II 10% W/ ELECTROLYTES's compliance with AMINOSYN II 10% W/ ELECTROLYTES specifications and serves as a tool for batch-level quality control.
AMINOSYN II 10% W/ ELECTROLYTES CoA mostly includes findings from lab analyses of a specific batch. For each AMINOSYN II 10% W/ ELECTROLYTES CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
AMINOSYN II 10% W/ ELECTROLYTES may be tested according to a variety of international standards, such as European Pharmacopoeia (AMINOSYN II 10% W/ ELECTROLYTES EP), AMINOSYN II 10% W/ ELECTROLYTES JP (Japanese Pharmacopeia) and the US Pharmacopoeia (AMINOSYN II 10% W/ ELECTROLYTES USP).